We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.3B
AUM Growth
+$344M
Cap. Flow
-$120M
Cap. Flow %
-1.64%
Top 10 Hldgs %
25.93%
Holding
453
New
22
Increased
155
Reduced
213
Closed
25

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$71.7M
2
TFC icon
Truist Financial
TFC
+$56.3M
3
OXY icon
Occidental Petroleum
OXY
+$45.9M
4
VTR icon
Ventas
VTR
+$23.4M
5
SE
Spectra Energy Corp Wi
SE
+$23.1M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$80.4M
2
KMI icon
Kinder Morgan
KMI
+$55.8M
3
MRSH
Marsh
MRSH
+$55.4M
4
USB icon
US Bancorp
USB
+$47.7M
5
TWX
Time Warner Inc
TWX
+$35.9M

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Consumer Staples 15.34%
3 Financials 15.05%
4 Healthcare 14.65%
5 Industrials 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
101
ResMed
RMD
$32.4B
$8.97M 0.12%
167,018
-1,180
-0.7% -$66.5K
DOV icon
102
Dover
DOV
$28.3B
$8.03M 0.11%
162,044
-5,316
-3% -$270K
BRK.B icon
103
Berkshire Hathaway Class B
BRK.B
$1.12T
$8.01M 0.11%
60,669
+797
+1% +$107K
TFX icon
104
Teleflex
TFX
$6.2B
$7.74M 0.11%
58,901
-283
-0.5% -$36.8K
VIRT icon
105
Virtu Financial
VIRT
$5.03B
$7.63M 0.1%
336,918
+119,796
+55% +$2.75M
O icon
106
Realty Income
O
$58.7B
$7.17M 0.1%
143,239
+32,029
+29% +$1.53M
HCSG icon
107
Healthcare Services Group
HCSG
$1.59B
$6.58M 0.09%
188,739
-4,090
-2% -$149K
FISV
108
Fiserv Inc
FISV
$29.7B
$6.56M 0.09%
143,394
-2,400
-2% -$113K
APD icon
109
Air Products & Chemicals
APD
$65.6B
$6.41M 0.09%
53,249
-12,463
-19% -$1.57M
T icon
110
AT&T
T
$160B
$6M 0.08%
231,019
-13,054
-5% -$331K
GNTX icon
111
Gentex
GNTX
$5.14B
$5.68M 0.08%
354,765
+21,230
+6% +$343K
COR icon
112
Cencora
COR
$59.6B
$5.53M 0.08%
53,331
-4,709
-8% -$462K
IYW icon
113
iShares US Technology ETF
IYW
$25.1B
$5.3M 0.07%
198,108
+468
+0.2% +$12.6K
XLNX
114
DELISTED
Xilinx Inc
XLNX
$5.19M 0.07%
110,440
-1,045
-0.9% -$49.4K
FITB
115
Fifth Third Bancorp
FITB
$52.4B
$4.52M 0.06%
224,852
-1,689
-0.7% -$33.5K
ARG
116
DELISTED
Airgas Inc
ARG
$4.5M 0.06%
32,570
-1,042
-3% -$120K
BCPC
117
Balchem Corp
BCPC
$5.57B
$4.46M 0.06%
73,356
+792
+1% +$51.4K
STE icon
118
Steris
STE
$22.7B
$4.46M 0.06%
59,156
-830
-1% -$60K
KHC icon
119
Kraft Heinz
KHC
$31.6B
$4.4M 0.06%
60,493
-4,405
-7% -$325K
JKHY icon
120
Jack Henry & Associates
JKHY
$11.1B
$4.19M 0.06%
53,676
-650
-1% -$49.9K
COP icon
121
ConocoPhillips
COP
$144B
$4.18M 0.06%
89,441
-13,820
-13% -$722K
WPC icon
122
W.P. Carey
WPC
$16.5B
$4.17M 0.06%
72,173
+304
+0.4% +$18.2K
DCI icon
123
Donaldson
DCI
$11.4B
$4.1M 0.06%
143,055
-15,044
-10% -$443K
IBM icon
124
IBM
IBM
$222B
$3.98M 0.05%
30,235
-8,164
-21% -$1.1M
CLX icon
125
Clorox
CLX
$12.7B
$3.74M 0.05%
29,477
-1,597
-5% -$198K

Similar funds

Bahl & Gaynor's Q4 2015 Portfolio in Review

As of Q4 2015, Bahl & Gaynor held 453 positions worth $7.3B, up 4.9% from $6.96B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Bahl & Gaynor's Q4 2015 filing shows 22 new, 155 increased, 213 reduced and 25 closed positions. Its largest new stake was Equifax: 109,123 shares worth $12.2M. The largest sale was Williams Companies, an estimated $80.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Staples and Financials.

  • Bahl & Gaynor's largest Q4 2015 buy was Equifax: 109,123 shares worth $12.2M.
  • Bahl & Gaynor added most to Crown Castle in Q4 2015, an estimated $71.7M increase.
  • Bahl & Gaynor's biggest Q4 2015 reduction was Williams Companies, cutting an estimated $80.4M.
  • Bahl & Gaynor fully exited Kinder Morgan in Q4 2015, selling an estimated $55.8M.
  • Bahl & Gaynor's ten largest holdings make up 26% of its $7.3B portfolio in Q4 2015.
  • Bahl & Gaynor opened 22 new positions and closed 25 in Q4 2015.
  • Bahl & Gaynor's portfolio value rose 4.9% quarter-over-quarter to $7.3B.

Based on Bahl & Gaynor's 13F filing for Q4 2015, filed 12 Feb 2016.